Influence of Clinical Parameters on the Efficacy of Immune Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer Brain Metastases (NSCLCBM)

被引:0
|
作者
Lauko, Adam
Thapa, Bicky
Muhsen, Baha'eddin
Borghei-Razavi, Hamid
Chao, Samuel
Suh, John
Pennell, Nathan
Ahluwalia, Manmeet
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
418
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?
    Hendriks, Lizza E. L.
    Remon, Jordi
    Menis, Jessica
    Besse, Benjamin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2868 - 2875
  • [32] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [33] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [34] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [35] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [36] Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application
    Xiao, Gang
    Liu, Zhiyuan
    Gao, Xuan
    Wang, Han
    Peng, Haiqin
    Li, Jiahui
    Yang, Lei
    Duan, Hexin
    Zhou, Rongrong
    IMMUNOTHERAPY, 2021, 13 (12) : 1031 - 1051
  • [37] Adverse impact of bone metastases on clinical outcomes of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Li, Xing
    Wang, Lei
    Chen, Shanhao
    Zhou, Fei
    Zhao, Jing
    Zhao, Wencheng
    Su, Chunxia
    THORACIC CANCER, 2020, 11 (10) : 2812 - 2819
  • [38] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations
    Xiaoling Shang
    Wengang Zhang
    Wenfei Han
    Handai Xia
    Ni Liu
    Xiuwen Wang
    Yanguo Liu
    BMC Pulmonary Medicine, 23
  • [39] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations
    Shang, Xiaoling
    Zhang, Wengang
    Han, Wenfei
    Xia, Handai
    Liu, Ni
    Wang, Xiuwen
    Liu, Yanguo
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [40] The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
    Kitadai, Rui
    Okuma, Yusuke
    Hakozaki, Taiki
    Hosomi, Yukio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 777 - 785